Google Deepmind has unveiled AlphaGenome 2, an AI model that analyzes genetic variants for individual cell types rather than across bulk tissue. Trained on more than 107 million cell profiles, it identifies nearly twice as many disease-relevant gene changes as its predecessor. The model is available for noncommercial research through an API and is set to be integrated into Google's agentic platform Antigravity.
The article Google Deepmind shifts genomics AI from bulk tissue predictions to single cell type resolution with AlphaGenome 2 appeared first on The Decoder.
source & further reading
the-decoder.com — original article
Google joins the decision-model wave with Gemini Decision 1, scoring 1,000 questions in a single pass
Google Deepmind's AlphaProof Code verified Signal's cryptographic core in four weeks instead of years
DeepL wants real-time translation to finally capture sarcasm and mood shifts